An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders
PHASE4CompletedINTERVENTIONAL
Enrollment
245
Participants
Timeline
Start Date
September 30, 2012
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
Conditions
Spinal Disorder
Interventions
DRUG
Buprenorphine
8weeks treatment with Norspan®(Buprenorphine)
Trial Locations (1)
Unknown
Samsung Medical Center, Seoul
All Listed Sponsors
lead
Mundipharma Korea Ltd
INDUSTRY
NCT01818700 - An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders | Biotech Hunter | Biotech Hunter